Wyeth Pharmaceuticals, the Wyeth division based in Collegeville, said today that the U.S. Food and Drug Administration approved Tygacil to treat adults with community-acquired bacterial pneumonia caused by susceptible strains of certain pathogens.
Philly.com Business, Philadelphia Inquirer & Daily News: Business
Tue, 03/24/2009 - 10:43am
Wyeth Pharmaceuticals, the Wyeth division based in Collegeville, said today that the U.S. Food and Drug Administration approved Tygacil to treat adults with community-acquired bacterial pneumonia caused by susceptible strains of certain pathogens.